Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 1,578 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arrhythmias Cardiac Clear all

Conditions: Atrial Fibrillation, Stroke
Interventions: On-screen electronic alert; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 798 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Deep Vein Thrombosis, Fibrillation, Atrial, Venous Thromboembolism, Pulmonary Embolism
Interventions: Odiparcil, Warfarin, Coumadin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 35 Years and older
Enrollment: 961 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 46
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 37 more

Conditions: Ventricular Pacing With Rate Response, Bradycardia
Interventions: Calyan Pacemaker; Device
Lead sponsor: Calyan Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation
Interventions: Sotalol, Dofetilide; Drug
Lead sponsor: Samir Saba; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Bradyarrhythmia, Heart Failure
Interventions: Data collection; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Tucson, Arizona • Chicago, Illinois • New York, New York + 2 more

Conditions: Arrythmia
Interventions: Ablation; Device
Lead sponsor: EPD Solutions, A Philips Company; Industry
Eligibility: 18 Years and older
Enrollment: 566 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 6
States / cities: Sacramento, California • Chicago, Illinois • Baltimore, Maryland + 3 more

Conditions: Systolic Heart Failure, Atrial Fibrillation (Permanent)
Interventions: Atrioventricular junctional (AVJ) ablation, Cardiac resynchronization therapy - defibrillator; Procedure · Device
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 21
States / cities: Little Rock, Arkansas • Pasadena, California • Atlanta, Georgia + 16 more

Conditions: Bradycardia
Interventions: Closed Loop Stimulation (CLS), Standard Rate Adaptive (R) Technology, Non-rate adaptive (DDD) pacing; Device
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,491 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 99
States / cities: Albertville, Alabama • Gadsden, Alabama • Jasper, Alabama + 82 more

Conditions: Atrial Fibrillation
Interventions: Atrial Fibrillation Ablation; Procedure
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years to 85 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Ventricular Arrhythmia
Interventions: Eleclazine, Placebo to match eleclazine; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 37
States / cities: Mesa, Arizona • Long Beach, California • Los Angeles, California + 32 more

Conditions: Bradycardia, Slow Heart Beat
Interventions: Implantable Pulse Generator (IPG) and Pacing Leads (wires), Magnetic Resonance Imaging (MRI) scan; Device · Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 15
States / cities: Redwood City, California • Salinas, California • Orlando, Florida + 12 more

Conditions: Ventricular Tachycardia
Interventions: Boston Scientific Vessix Renal Denervation System; Device
Lead sponsor: Vivek Reddy; Other
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: New York, New York • Austin, Texas

Conditions: Atrial Fibrillation
Interventions: Botulinum Toxin Type A, Placebo; Drug
Lead sponsor: Joseph Mathew, M.D.; Other
Eligibility: 50 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Venous Thrombosis, Atrial Fibrillation, Atrial Flutter
Interventions: Genotype-guided dosing algorithm for warfarin, Clinical-guided dosing algorithm for warfarin; Behavioral
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 1,015 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 18
States / cities: Birmingham, Alabama • San Francisco, California • Gainesville, Florida + 15 more

Conditions: Paroxysmal Atrial Fibrillation
Interventions: FARAPULSE Pulsed Field Ablation System, RadioFrequency and Cryoballoon Ablation; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 34
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 23 more

Conditions: Paroxysmal Atrial Fibrillation
Interventions: Ablation; Device
Lead sponsor: Hansen Medical; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 9
States / cities: Mesa, Arizona • Rochester, Minnesota • Englewood, New Jersey + 6 more

Conditions: Atrial Fibrillation
Interventions: OFDI Capsule; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation
Interventions: MIFI Catheter, Standard Ablation Catheter; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Typical Atrial Flutter, Risk Factors With Future Development of Atrial Flutter
Interventions: CTI ablation alone, CTI ablation and Pulmonary vein isolation (PVI); Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atrial Fibrillation
Interventions: Anti Arrhythmics, Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation; Drug · Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 5
States / cities: Tucson, Arizona • The Bronx, New York • Cleveland, Ohio + 1 more

Conditions: Rapid Atrial Fibrillation, Heart Rate Control
Interventions: Dexmedetomidine Hydrochloride, Normal Saline; Drug · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Atrial Fibrillation, Arrythmia
Interventions: MindMics; Device
Lead sponsor: MindMics Inc; Industry
Eligibility: Not listed
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sumter, South Carolina

Conditions: Long QT Syndrome
Interventions: LQT-1213, Placebo, Dofetilide 250 μg Cap; Drug
Lead sponsor: Thryv Therapeutics, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: West Bend, Wisconsin

Conditions: Atrial Fibrillation
Interventions: Kardia Monitoring; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

Odiparcil For The Prevention Of Venous Thromboembolism

Chronic Evaluation of Novel Pacemaker System

Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

Conduction System Pacing International Registry (CONSPIRE)

Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study

Junctional AV Ablation in CRT-D: JAVA-CRT

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Comparing Surgical Management Methods of Atrial Fibrillation

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

EMRI SureScan™ Clinical Study

REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients

Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery

Clarification of Optimal Anticoagulation Through Genetics

The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation

Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation

OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation

Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation

Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Controlling Rapid Atrial Fibrillation With Dexmedetomidine

Design and Rationale of the Assessment of the MindMics Recording System

Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).

A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure